Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury – A systematic review

•NGAL appeared to have a predictive value irrespective of age, from newborn to 78 years.•Urinary and serum NGAL appears to be an independent predictor of not only kidney complications but also diseases of cardiovascular and liver origin.•Both urinary and plasma NGAL could be an early diagnostic mark...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2022-11, Vol.536, p.135-141
1. Verfasser: Marakala, Vijaya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•NGAL appeared to have a predictive value irrespective of age, from newborn to 78 years.•Urinary and serum NGAL appears to be an independent predictor of not only kidney complications but also diseases of cardiovascular and liver origin.•Both urinary and plasma NGAL could be an early diagnostic marker for acute kidney injury and a prognostic marker for assessing the severity and complications in addition to the prediction of survival. Neutrophil Gelatinase Associated Lipocalin (NGAL) is a secretory protein of neutrophils that can be found both in plasma and urine. Previous works have demonstrated a valuable marker for the early detection of acute kidney injury. In this systematic review, we aimed to assess whether NGAL could be helpful in the diagnosis and prognosis of systemic diseases with kidney involvement. MEDLINE, PubMed, and EMBASE databases were searched for NGAL, described as a human biomarker for diseases (total: 1690). Specifically, included studies describing the use of NGAL for determining kidney injury outcomes and other conditions associated with kidney dysfunction, including cardiovascular diseases, cardiac surgery, and critically ill systemic disorders. A total of 24 validated studies were included in the systemic review after applying the exclusion criteria. In all these studies, NGAL appeared to have a predictive value irrespective of age, from newborn to 78 years. The results indicate that NGAL levels can accurately predict the outcome and severity of acute kidney injury occur in several disease processes, including contrast-induced AKI during cardiac surgery, kidney transplant rejection, chronic heart failure, and systemic inflammation in critically ill patients, even though the significance of NGAL is highly variable across studies. Very high plasma NGAL levels were observed in the patients before the acute rejection of the kidney, indicating the prognostic potential of the NGAL. Specifically, the assays conducted before 72 hrs provided a significant predictive value. Urinary and serum NGAL appears to be an independent predictor of not only kidney complications but also cardiovascular and liver-related diseases. The kidney is also involved in pathogenesis.
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cca.2022.08.029